Qun Wu is a Psychiatry physician affiliated with Johnson & Johnson. OpenAlex indexes 58 publications with 1,904 citations (h-index 22); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
8555 Taft St
Merrillville, IN 464106123
Telephone
773-490-1544Provider last certified this registry record 16 Jul 2025.
Clinical trials
- Using Cryoballoon Ablation as Initial Treatment for Persistent Atrial Fibrillation
Sponsor: Ruijin Hospital
- Comparison of RF and crYoballoon ablatiOn Therapy of AF（CRYO-AF）
Sponsor: Ruijin Hospital
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Otsuka America Pharmaceutical, Inc.Program year20251 payment
- E.R. Squibb & Sons, L.L.C.Program year20251 payment
- ABBVIE INC.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
95.8%SSRI27.8%Trazodone Hcl50%Sertraline Hcl19%Escitalopram Oxalate9%Citalopram Hbr9%Fluoxetine Hcl7%Paroxetine Hcl5%Part D<11 patientsAtypical Antipsychotic16.8%Aripiprazole41%Quetiapine Fumarate33%Risperidone11%Olanzapine9%Quetiapine Fumarate Er4%Vraylar4%Part D<11 patients+ 14 more classes in this area
Cardiovascular
4.2%alpha-Adrenergic Blocker3.5%Prazosin Hcl100%Part D≥13 patientsCentral alpha-2 Adrenergic Agonist0.6%Clonidine Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- TRIM25 promotes glioblastoma cell growth and invasion via regulation of the PRMT1/c-MYC pathway by targeting the splicing factor NONO
Journal of Experimental & Clinical Cancer Research
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Wayne Drevets, MD
Johnson & Johnson
Matthew Breyer, MD
Johnson & Johnson
Deepu Madduri, MD
Johnson & Johnson
Elliot Barnathan, MD
Johnson & Johnson
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”